SKI Market

A+| A| A-|

Indian Indices

Sensex

77,186.87 1.44
( 0.00%)

Global Indices

Nasdaq

52,569.33 -110.31
(-0.21%)

Dow Jones

7,555.54 -37.86
(-0.50%)

Hang Seng

66,873.37 -1,878.14
(-2.73%)

Nikkei 225

10,555.24 39.32
(0.37%)

Forex

USD-INR

96.14 0.39
(0.40%)

EUR-INR

109.70 0.52
(0.48%)

GBP-INR

128.61 0.54
(0.42%)

JPY-INR

0.59 0.00
(0.41%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530019

INE700A01033

145.1556811

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JUBLPHARMA

16250.19

EPS(TTM)

Face Value()

Div & Yield %

1.97

0.49

Back

Devyani International reports consolidated net loss of Rs 10.39 crore in the December 2025 quarter

Feb 04,2026

Net Loss of Devyani International reported to Rs 10.39 crore in the quarter ended December 2025 as against net loss of Rs 0.49 crore during the previous quarter ended December 2024. Sales rose 11.32% to Rs 1440.90 crore in the quarter ended December 2025 as against Rs 1294.40 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1440.90	1294.40	11
OPM %	16.03	16.47	-
PBDT	173.24	155.28	12
PBT	6.59	8.52	-23
NP	-10.39	-0.49	-2020

77,186.87 1.44 ( 0.00%)

52,569.33 -110.31 (-0.21%)

7,555.54 -37.86 (-0.50%)

66,873.37 -1,878.14 (-2.73%)

10,555.24 39.32 (0.37%)

96.14 0.39 (0.40%)

109.70 0.52 (0.48%)

128.61 0.54 (0.42%)

0.59 0.00 (0.41%)